Amneal Pharmaceuticals Inc. [AMRX] BOYER ANDREW S sells 29,302 Shares for $0.12 million


Amneal Pharmaceuticals Inc.’s recent filing unveils that its Executive Vice President BOYER ANDREW S unloaded Company’s shares for reported $0.12 million on Aug 11. In the deal valued at $4.13 per share,29,302 shares were sold. As a result of this transaction, BOYER ANDREW S now holds 244,739 shares worth roughly $ 0.93 million.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Then, TPG GP A, LLC sold 3,884,600 shares, generating $9,095,402 in total proceeds. Upon selling the shares at $2.34, the Former 10% Owner now owns 12,328,767 shares.

PT values the company’s stock at a premium of 23.6 to its Tuesday closing price.

Price Performance Review of AMRX

On Tuesday, Amneal Pharmaceuticals Inc. [NYSE:AMRX] saw its stock fall -9.48% to $3.82. On the same session, the stock had its day’s lowest price of $3.81, but rose to a high of $4.25. Over the last five days, the stock has lost -6.37%. Amneal Pharmaceuticals Inc. shares have risen nearly 91.96% since the year began. Nevertheless, the stocks have risen 63.25% over the past one year. While a 52-week high of $4.74 was reached on 08/07/23, a 52-week low of $1.24 was recorded on 03/28/23. SMA at 50 days reached $3.51, while 200 days put it at $2.44. A total of 0.96 million shares were traded, compared to the trading of 1.4 million shares in the previous session.

Levels Of Support And Resistance For AMRX Stock

The 24-hour chart illustrates a support level at 3.67, which if violated will result in even more drops to 3.52. On the upside, there is a resistance level at 4.11. A further resistance level may holdings at 4.40. The Relative Strength Index (RSI) on the 14-day chart is 49.44, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.08, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 70.19%. Stochastics %K at 62.94% indicates the stock is a holding.

How much short interest is there in Amneal Pharmaceuticals Inc.?

A steep rise in short interest was recorded in Amneal Pharmaceuticals Inc. stocks on Aug 14, 2023, dropping by -0.66 million shares to a total of 3.49 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 4.15 million shares. There was a decline of -18.91%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 2.88% of the overall stock float, the days-to-cover ratio (short ratio) fell to 2.92.

Amneal Pharmaceuticals Inc. [AMRX] – Who Are The Largest Shareholders?

In filings from The Vanguard Group, Inc., it is revealed that the company now owns 12,841,038 shares, or roughly 8.37% of the outstanding AMRX shares. In other words, the investor’s shares have risen by 14,164 from its previous 13-F filing of 12826874.0. Additionally, BlackRock Fund Advisors increased 16.46% of its stake after which the total value it holdings stand at $23,118,186, while Eversept Partners LP added 1.59% of its stake to hold $16.85 million in the firm. Over the last quarter, Neuberger Berman Investment Advis purchased 65,312 shares of Amneal Pharmaceuticals Inc., while Norges Bank Investment Management bought 2,714,400 shares. At present, Rubric Capital Management LP is holding 2,601,379 shares valued at $8.32 million. SSgA Funds Management, Inc. owned 2,230,737 shares of the company at the time of its most recent 13F filing, worth $7.14 million.

According to FactSet, Amneal Pharmaceuticals Inc.’s share price will average $5.25 in the next year, based on opinions of analysts polled by the firm. This is up nearly 18.48 percent from its previous closing price of $4.22. Analysts expect Amneal Pharmaceuticals Inc. stock to reach the higher price of $6.00, while the lowest price estimate is $5.00. However, 5 analysts have rated AMRX stock as an Overweight in their predictions for 2023.


Please enter your comment!
Please enter your name here